The tenth annual #MedSafetyWeek brings together more than 130 medicines regulators and health organisations across 117 countries to encourage people to report suspected side effects from medicines and device incidents.
Similar Posts
MHRA smashes major illicit weight loss medicine production facility in record seizure
MHRA strikes massive blow to organised criminal gang in world’s biggest illegal weight loss jabs raid.
Mesalazine and idiopathic intracranial hypertension
Idiopathic intracranial hypertension (IIH) has been very rarely reported in patients treated with mesalazine. Following a recent review, warnings for IIH are being added to the product information for all mesalazine products.
AI breakthroughs drive expansion of ‘Airlock’ testing programme to support AI-powered healthcare innovation
MHRA opens second round of applications to test cutting-edge AI medical technologies following successful pilot phase.
Clinical trials for medicines: ending a clinical trial
Guidance on the process for ending a clinical trial.
Field Safety Notices: 18 to 22 August 2025
List of Field Safety Notices from 18 to 22 August 2025.
Decision: Marketing authorisations granted in 2025
Marketing authorisations granted in 2025.